On Friday, MiMedx Group Inc (NASDAQ:MDXG)’s shares declined -2.65% to $11.02.
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
S&P 500 constituent The Priceline Group Inc. will replace Baxter International Inc. in the S&P 100, Baxalta Inc. will replace QEP Resources Inc. in the S&P 500, QEP Resources will replace Itron Inc. in the S&P MidCap 400, and Itron will replace Arch Coal Inc. in the S&P SmallCap 600 after the close of trading on Tuesday, June 30. Baxter International is spinning off Baxalta in a transaction predictable to be accomplished on that date. Baxter International will remain in the S&P 500 following the distribution, but its post spin market capitalization will no longer make it appropriate for the S&P 100. QEP Resources, Itron and Arch Coal are all ranked near or at the bottom of their current indices.
Skechers USA Inc. will replace Rock-Tenn Co. in the S&P MidCap 400, and MiMedx Group Inc. (MDXG) will replace Skechers USA in the S&P SmallCap 600 after the close of trading on Tuesday, June 30. S&P 500 constituent MeadWestvaco Corp. (MWV) is combining with Rock-Tenn in a transaction predictable to be accomplished on or about that date. The combined company will remain in the S&P 500 and will change its name to WestRock Co.
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix. The companys AmnioFix and EpiFix are tissue technologies processed from human amniotic membrane derived from donated placentas. Through its donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste.
Bank of Montreal (USA) (NYSE:BMO)’s shares gained 0.08% to $60.00.
Bank of Montreal (USA) (BMO) declared the June 2015 cash distributions for certain BMO Exchange Traded Funds (ETFs)* that distribute either monthly or quarterly. Unitholders of record of the BMO ETFs at the close of business on June 29, 2015 will receive cash distributions payable on July 7, 2015.
Bank of Montreal offers various banking products and services in Canada, the United States, and internationally. The company’s personal and commercial banking products and services comprise chequing and savings accounts; banking services, counting 24/7 banking, direct deposits, bill payments, overdraft services, money transfers, wire transfers, and travel insurance; credit cards; mortgages; loans and lines of credit; and creditor insurance.
At the end of Friday’s trade, Western Digital Corp (NASDAQ:WDC)‘s shares dipped -1.51% to $91.02.
Western Digital Corp (WDC) declared that it has added Paul S. Michaels, former Global President of Mars, Incorporated, to the company’s Board of Directors.
Paul S. Michaels will bring extensive consumer goods experience to Coty. During his time at Mars, he led efforts to strengthen the company’s portfolio of businesses through brand revitalization and product innovation. Paul S. Michaels and his team are credited with achieving record growth by refocusing Mars on its core business, emphasizing operational efficiency and developing a high-performance culture.
Western Digital Corporation, through its auxiliaries, develops, manufactures, and sells data storage solutions that enable consumers, businesses, governments, and other organizations to create, manage, experience, and preserve digital content. It provides hard disk drives (HDDs) and solid-state drives for desktop and notebook personal computers (PCs), and performance enterprise and capacity enterprise markets.
IsoRay, Inc. (NYSEMKT:ISR), ended its Friday’s trading session with -1.25% loss, and closed at $1.58.
IsoRay, Inc. (ISR) declared the appointment, on June 18, 2015, of Michael (Mick) McCormick, former Executive Vice President of Global Sales and Marketing of Columbia Sportswear, to its Board of Directors.
Mr. McCormick will serve on the Audit and Compensation Committees of the Board, and will chair the Nominating and Corporate Governance Committee of the Board.
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, in addition to ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, counting primary and recurrent gliomas and metastic brain tumors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
